Abolition of the central cardiovascular effects of angiotensin by ablation of the area postrema.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001812:Blood-Brain Barrier; D002319:Cardiovascular System / Q000187:drug effects*; D002339:Carotid Arteries; D004285:Dogs; D008526:Medulla Oblongata / Q000502:physiology*; D011453:Prostaglandins / Q000494:pharmacology
D011453:Prostaglandins; D000804:Angiotensin II; D000109:Acetylcholine